HP drug regulator suspends Wockhardt product
To revoke the said suspension, the company is filing an appeal before the State Government under the provisions of applicable law
Wockhardt Ltd has informed BSE that the State Drug Controller, Himachal Pradesh, has suspended the manufacture, sale or distribution of fixed dose combination (FDC) dicyclomine hydrochloride IP 10 mg, tramadol hydrochloride IP 50 mg and acetamenophen IP 325 mg. The company in order to revoke the said suspension is filing an appeal before the State Government under the provisions of applicable law. The product contributed less than 3% of the consolidated sales of Wockhardt during the Financial Year 2013-14.